Adiposity has unique influence on the renin-aldosterone axis and blood pressure in black children by Yu, Zhangsheng et al.
Adiposity has Unique Influence on the Renin-Aldosterone Axis
and Blood Pressure in Black Children
Zhangsheng Yu, PhD1, George Eckert, MA1, Hai Liu, PhD1, J. Howard Pratt, MD1,2, and
Wanzhu Tu, PhD1,3
1Indiana University School of Medicine, Indianapolis, Indiana
2Richard L. Roudebush Veteran’s Administration Medical Center, Indianapolis, Indiana
3Regenstrief Institute, Inc., Indianapolis, Indiana
Abstract
Objective—To comparatively examine the effects of adiposity on the levels of plasma renin
activity (PRA), plasma aldosterone concentrations (PAC), and aldosterone-renin ratios (ARR) in
young black and white children.
Study design—We prospectively assessed 248 black and 345 white children and adolescents. A
novel analytical technique was used to assess the concurrent influences of age and body mass
index (BMI) on PRA, PAC, and ARR. The estimated effects were depicted by colored contour
plots.
Results—In contrast to whites, blacks had lower PRA (2.76 vs 3.36 ng/ml/h; p<0.001) and lower
PAC (9.01 vs 14.59 ng/dl; p<0.001). In blacks, BMI was negatively associated with PRA
(p=0.001), consistent with an association with a more expanded plasma volume; there was no
association with PAC. In whites, BMI was positively associated with PAC (p=0.005); we did not
detect a BMI-PRA association. The effects of BMI on ARR were directionally similar in the two
race groups but more pronounced in blacks. Mean systolic BP was greater in blacks with lower
PRA (p<0.01), higher PAC (p=0.015), and higher ARR (p=0.49).
Conclusions—An increase in adiposity was associated with a suppressed PRA in blacks and an
increase in PAC in whites. The unique relationship between adiposity and renin-aldosterone axis
in blacks suggests the possible existence of a population-specific mechanism characterized by
volume expansion, which could in turn enhance the influences of adiposity on BP in black
children and adolescents.
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Although blood pressures and rates of onset of hypertension are typically much lower in
children and adolescents than in adults, recent epidemiological data indicate a shift of the
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disease toward young people, possibly a result of the marked increase in childhood
obesity.1, 2 Indeed, most cases of hypertension in children and adolescents are accompanied
by obesity, defined as body mass index or BMI greater than 30 kg/M2.3 The mechanism for
how obesity raises the level of BP is not fully understood. Rocchini et al, in a study of obese
and non-obese adolescents, found that the higher BP in obese subjects was characterized as
being salt-sensitive.4 They also found that the PAC was higher in obese hypertensive
adolescents than in non-obese adolescents, whereas the level of PRA was unrelated to BMI.
Other investigative groups have also found that PAC was increased when BMI was
increased.5–7
Compared with whites, blacks are more prone to develop hypertension regardless of age.8
Even before there is any increase in BP, blacks show evidence for increased sodium
reabsorption to the extent that PRA and PAC are often lower.9, 10 This raises the question of
whether influences of BMI on BP regulation are different in blacks and whites. Previous
studies on the effects of BMI have for the most part not provided information on race
groups. In the present study, we address the question of whether the renin-aldosterone axis
in relationship to adiposity is different in blacks and whites, by analyzing data from a
biracial cohort of children and adolescents.
METHODS
The study design and data collection process were previously described.11, 12 Briefly,
subjects were healthy black and white young people recruited from 33 participating schools
in Indianapolis. The schools were selected to provide a range in socioeconomic status. Those
with a history of cardiac and kidney diseases, hypertension, diabetes mellitus, and those
taking medications that can affect BP were excluded. Although subjects were followed
prospectively with measurements of blood pressure, height, and weight at six month
intervals, analyses were limited to data collected during visits when blood samples were
obtained for measurement of PRA and PAC. Aldosterone-renin activity ratio (ARR) was
calculated as PAC/PRA. BMI was calculated from the height and weight (BMI=weight /
height2). Other adiposity measures such as waist and hip circumferences, tricep and
subscapular skinfold were ascertained at the time of visit. Overnight urine samples were
collected and sodium (Na) and potassium (K) excretion rates were calculated per unit of
creatinine. The study protocol was approved by the Indiana University Institutional Review
Board. All subjects (and a parent) provided written informed consent or assent as
appropriate.
PRA was measured using a radioimmunoassay for generated angiotensin I (Clinical Assays,
GammaCount radioimmunoassay kit from Diasorin), and PAC was measured using a
radioimmunoassay (Coat-A-Count kit from Diagnostic Products Corporation).
Statistical analyses
Subjects’ race was self-reported. As part of the analysis, we examined the data distributions
of continuous variables; skewed data were transformed using logarithmic transformation
before analysis. Log-transformed values were then compared between the races using
generalized estimating equation models (GEE). Binary variables were compared using Chi-
square tests. To accommodate the potentially nonlinear influences of adiposity on PRA,
PAC, and ARR, we used semiparametric regression models to examine the BMI effects on
these outcomes. Semiparametric regression is a class of statistical methods that are most
useful for the exploration of nonlinear relationships and it does not restrict the depicted
relation to a linear form.13 To simultaneously account for the age-related changes in PRA,
PAC, and ARR, we expressed each of these outcomes as a smooth bivariate function of age
and BMI, eg. log(PRA) = f(age, BMI). The predicted levels of the response variable at
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different age-BMI combinations were presented as colored contour plots, in which the color
scheme and contour lines indicate the mean response levels. A main advantage of this
analytical approach is that it allows for the examination of adiposity effect on the outcome
variable at any given age in the study population. Separate models were fitted for black and
white subjects. The analysis was implemented using mgcv package in R software (Version
2.11).14 To test the individual effects of age and BMI on the response variable, we further
fitted linear models. For each of the outcomes, the estimated effects of BMI, and BMI-race
interaction were reported in a tabular form along with their corresponding p-values. Other
adiposity measures were analyzed in a similar manner. As a sensitivity analysis, we also
compared the levels of PRA, PAC, and ARR in normal weight and overweight/obese
children using age and sex adjusted BMI percentile values.15 Finally, we dichotomized
PRA, PAC, and ARR levels at their sample median values and examined mean and 95%
confidence intervals of systolic BP corresponding to the dichotomized categories. In all
analysis, p values less than 0.05 were considered statistically significant.
RESULTS
Five hundred ninety-three subjects contributed a total of 728 visits where blood samples
were collected. Of these, 134 subjects contributed multiple blood samples during the course
of follow-up. Demographical and clinical characteristics of the study subjects are presented
in Table I. On average, blacks were slightly younger than whites (14.21 vs. 15.10 years; p <
0.001), and had greater BMI (24.41 vs. 22, p < 0.001), greater tricep skinfold (18.3 vs
16.3mm; p=0.002) and great subscapular skinfold (16.9 vs 12.9mm; p<0.0001). There was
no significant difference in systolic BP between blacks and whites (108.79 vs 108.41
mmHg; p-value = 0.682). Mean diastolic BP was higher in blacks than in whites (67.10 vs.
65.28 mmHg, p=0.025). Compared with whites, blacks had a lower PRA (2.76 vs. 3.36 ng/
ml/h, p-value < 0.001), lower PAC (9.01 vs. 14.59 ng/dl, p-value < 0.001), and slightly
lower ARR (5.00 vs. 5.57 ng/dl per ng/ml/h), but the difference in ARR did not reach the
level of statistical significance (p-value = 0.249). We did not detect a sex difference in BMI
when age and race were adjusted (BMI=22.89 in males and 23.14 in females; adjusted p
value = 0.8049), nor did we detect significance sex difference in PRA and PAC levels
(p=0.9872 and 0.4376, respectively). There were no sex differences in BMI, PRA, and PAC
within individual race groups. Urinary excretion rates of Na and K were not significantly
different between the races.
Smooth surface estimates of age and BMI effects on PRA, PAC, and ARR in black and
white subjects are presented in Figure 1. In each plot, we presented mean values of the
response variable at all age-BMI combination. The magnitude of the response was indicated
by colors and numbers on the contour lines. Race differences were evident in the effects of
BMI on PAC, PRA, and ARR. For example, blacks had on average lower PAC than whites,
and PAC increased with BMI at all ages in whites, but not in blacks (Figure 1, A and B).
Similarly, PRA was on average lower in blacks, especially for individuals with higher BMI
values. PRA decreased with BMI at all ages in blacks, but not in whites (Figure 1, C and D).
ARR increased with BMI and age in both races, but the magnitude of the increase was
greater in blacks, especially for older adolescents with greater BMI (Figure 1, F).
Figure 1 showed that the BMI effects on PAC, PRA, and ARR were largely linear. To
formally test the individual effects of BMI on these outcomes, we repeated the analysis
using linear models. The linear model fitting results were reported in Table II. These results
essentially confirmed what were observed in Figure 1. In whites, BMI was positively
associated with PAC after controlling for the effects of age and sex (β=0.020, p= 0.005). In
blacks, BMI was not significantly associated with PAC (p = 0.793). BMI effects on PRA
were different between black and white subjects (p = 0.005). In whites, BMI was not
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significantly associated with PRA (β = 0.004, p = 0.551). In blacks, PRA decreased with
increasing BMI (β = − 0.026, p = 0.001). BMI was positively associated with ARR in both
races, but the BMI effect on ARR was much more pronounced in blacks (β = 0.024, p =
0.010) than in whites (β = 0.015, p = 0.046). We similarly examined the relationships
between other adiposity measures (waist and hip circumferences, subscapular and tricep
skinfolds) and PRA, PAC, and ARR. The results essentially mirrored what we observed for
BMI (Table II).
We additionally examined the interactions between BMI percentile values and renin-
aldosterone axis by comparing the PRA, PAC, and ARR levels in normal weight and
overweight/obese children. The results remained consistent (Table III: available at
www.jpeds.com).
Finally, mean systolic BP values corresponding to dichotomized PRA, PAC, and ARR were
reported in Figure 2. Analysis showed that systolic BP was higher in blacks with lower PRA
(110 mmHg in individuals with lower PRA vs 106 mmHg in individuals with higher PRA;
p<0.01), higher PAC (111 mmHg in individuals with higher PAC vs 107 mmHg in
individuals with lower PAC; p=0.015), and higher ARR (111 mmHg in individuals with
higher ARR vs 108 mmHg in individuals with lower ARR; p=0.049). No significance
differences were detected in whites.
DISCUSSION
Obesity, which has taken on an alarmingly high prevalence and more so in blacks than in
whites,16, 17 is a major contributor to the risk for hypertension.18, 19 Previous studies in
adolescents as well as in adults have shown that levels of adiposity can be accompanied by
increases in aldosterone production.20, 2122, 23 In the present study, we also found that PAC
increased with BMI, but only in white subjects (Fig 1, A). In black subjects on the other
hand, there was little evidence that aldosterone production was related to BMI; instead, BMI
was inversely related to the level of PRA (Figure 1, B and D). Similar relationships were
consistently demonstrated in other adiposity measures where significant race differences
remained (Table II). A lower PRA is often regarded as an indication of expanded
extracellular fluid volume (ECFV) and PRA levels in blacks are known to be lower than that
of whites.24, 25 Our data showed that an increase in adiposity was accompanied by a
suppressed level of PRA in blacks whereas BMI and PRA were unrelated in whites
(aldosterone production in whites appeared to be predominantly driven by non-angiotensin
II stimuli; Figure 1, A and C).
Interestingly, in a recent study Visser et al measured ECFV in a group of white subjects and
found it to be proportional to BMI, but only after ECFV had first been expanded by a high
salt intake.26 Although we did not measure ECFV in the current study, we did observe a
relationship between adiposity and renin in blacks that is essentially parallel to the
observation of Visser et al on volume-expanded individuals. If blacks on average have a
more expanded volume than whites as some have suggested,27 this research would raise
logical questions of whether and how preexisting volume expansion, a result of sustained
increases in Na reabsorption (equivalent to the high salt intake used in the aforementioned
study) could sensitize volume to the influence of adiposity.
In the present study, ARR (PAC relative to the corresponding level of PRA) increased with
BMI in both race groups, although more so in blacks (Figure 1, E and F). The observation
supports the notion that a suppressed level of PRA could allow the lower PAC in blacks to
be physiologically relevant for increasing BP. It also offers an explanation for why in whites
BP did not increase as PAC increased in response to adiposity. The plasma volume may not
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have been sufficiently expanded in whites, a certain threshold may not have been reached to
allow the aldosterone to raise BP.
Despite the observational nature of the study, the findings may have clinical implication: If
blacks indeed retain more sodium than whites, being obese could certainly aggravate the risk
for hypertension. Considering the higher rates of both obesity and hypertension in blacks of
all ages,8, 17 the current research showed a synergistic adiposity effect that compounds
blacks’ susceptibility to hypertension through increased salt sensitivity. As our data showed,
the risk could be in existence even before the clinical manifestation of hypertension.
Therefore, early interventions directed at reducing obesity while simultaneously reducing
sodium intake may serve the health needs of blacks, possibly more than would be true for
whites. Furthermore, a racial disparity in blood pressure control could be based as much on
physiological differences as those related to socio-economics. Indeed, there may be a need
to develop population-specific treatment strategies for better blood pressure management in
children, especially when overweight or obese.
Methodologically, the current research highlights the utility of new analytical tools for data
exploration, such as the semiparametric regression techniques and related visualization tools
employed. These new analytical techniques assisted in revealing the subtle features of the
relationships that otherwise might have been overlooked.
We recognize several limitations to the current study. First, the focus on healthy young
people precluded the possibility of directly generalizing the findings to adult populations
where hypertension is more common. On the other hand, the current sample also presents an
opportunity for mechanistic exploration without interference that can occur when there is
hypertension including residual effects of treatment of hypertension. Second, as an
observational study, we did not control for or measure the dietary intake of Na and K in our
study subjects. But there is no indication that blacks consumed greater amount of Na than
whites in our study, as evidenced by the similar urinary Na and K excretion rates based on
overnight urine samples. Third, the lack of data on population groups other than blacks and
whites also limits the generalizability of the findings. Finally, as previous reviews have
noted, renin-aldosterone axis activation may just be one of the mechanisms that have the
potential to mediate the adiposity effect on blood pressure.28–30
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Figure 1.
Estimated effect contours of BMI and age on A and B, PAC, C and D, PRA, and E and F,
ARR in blacks and whites. In each plot, the mean levels of the response variables were
represented by colors with colder colors (blue) indicating lower values and warmer color
indicating higher values. The mean response levels, at all age-BMI combinations were
indicated by the numbers on the contour lines.
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Figure 2.
Mean systolic BP with 95% confidence intervals in black and white subjects with PRA,
PAC, and ARR below and above sample median values.
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Table 1
Characteristics of study subjects.
Black (n=248) White (n=345) p-value
Sex(male) 113(45.6%) 186 (53.9%) 0.054
Age(year) 14.21 (13.95, 14.46) 15.10 (14.84, 15.35) <0.001
BMI(kg/m2) 24.41(23.58, 25.23) 21.06 (21.61, 22.52) <0.001
SBP(mmHg) 108.79 (107.40, 110.18) 108.41 (107.22, 109.59) 0.682
DBP(mmHg) 67.10 (65.90, 68.28) 65.28 (64.23, 66.32) <0.025
PRA(ng/ml/h) 2.76 (2.51, 3.01) 3.36 (3.12, 3.60) <0.001
PAC (ng/dl) 9.01 (8.21, 9.82) 14.59 (13.66, 15.51) <0.001
ARR (ng/dl per ng/ml/h) 5.00 (4.11, 5.89) 5.57 (5.17, 5.97) 0.249
Urine Na excretion (mmol/gm) 90.4 (83.2, 97.7) 96.7 (90.2, 103.4) 0.208
Urine K excretion (mmol/gm) 23 (21, 25) 25 (22.8, 26.8) 0.147
Waist circumference (cm) 76.199(74.358,78.040) 74.332(73.143,75.521) 0.095
Hip circumference (cm) 96.022(94.301,97.744) 93.088(92.039, 94.136) 0.004
Triceps skinfold (mm) 18.348(17.268,19.429) 16.305(15.543,17.068) 0.002
Subscapular skinfold (mm) 16.884(15.778,17.989) 12.918(12.144,13.692) <0.001
Notes: BMI – Body mass index, SBP – systolic blood pressure, DBP – diastolic blood pressure, PRA – plasma renin activity, PAC – plasma
aldosterone concentration, ARR – aldosterone-renin ratio.
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Table 2
Effects of adiposity measures on renin-angiotensin axis in black and white subjects.
Dependent Variable Black (n=248) White (n=345) BMI-Race Interaction
Coefficient of BMI Coefficient of BMI P value
PRA* (ng/ml/h) −0.026 (p=0.001) 0.004 (p=0.551) 0.005
PAC* (ng/dl) −0.002 (p=0.793) 0.020 (p=0.005) 0.040
ARR* 0.024 (p=0.010) 0.015 (p=0.046) 0.413
Coefficient of Waist
Circumference
Coefficient of Waist
Circumference
Waist Circumference-Race Interaction; P
value
PRA* (ng/ml/h) −0.011(0.003) 0.003(0.229) 0.0018
PAC* (ng/dl) 0.003(0.417) 0.008 (0.008) 0.304
ARR* 0.014(0.001) 0.004(0.144) 0.072
Coefficient of hip circumference Coefficient of hip circumference Hip-Race Interaction; P value
PRA* (ng/ml/h) −0.012(0.001) −0.0002(0.943) 0.016
PAC* (ng/dl) 0.001(0.787) 0.010(0.003) 0.112
ARR* 0.013(0.003) 0.010(0.004) 0.539
Coefficient of triceps skinfold Coefficient of triceps skinfold Triceps-Race Interaction; P value
PRA* (ng/ml/h) −0.006(0.288) 0.009 (0.040) 0.039
PAC* (ng/dl) −0.0001(0.977) 0.016(0.0002) 0.021
ARR* 0.006(0.350) 0.007(0.143) 0.947
Coefficient of subscapular skinfold Coefficient of subscapular skinfold Subscapular skinfold-Race interaction; P
value
PRA* (ng/ml/h) −0.016(0.004) 0.006(0.152) 0.002
PAC* (ng/dl) −0.003(0.659) 0.020(<0.001) 0.002
ARR* 0.013(0.026) 0.014(0.002) 0.982
Notes:
*
Logarithmic transformation was performed on PRA, PAC, and ARR before analysis due to strong skewness in the data. In this table, we reported
regression coefficients of BMI, waist and hip circumferences, and triceps and subscapular skinfold on each dependent variable as well as the
corresponding p-values (in parentheses) in each race group (column). We also reported p values for the adiposity-race interaction, which tests the
difference of coefficients between blacks and whites.
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